Recursion Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ARK INVESTMENT MANAGEMENT LLC | 05/07/2025 | 34.82 M | $184.17 M | 7.63% | 8.64% |
VANGUARD GROUP INC | 05/09/2025 | 32.29 M | $170.80 M | -5.06% | 8.02% |
BAILLIE GIFFORD & CO | 05/07/2025 | 24.39 M | $129.04 M | -1.89% | 6.06% |
BLACKROCK, INC. | 05/02/2025 | 23.51 M | $124.35 M | 0.30% | 5.84% |
SOFTBANK GROUP CORP. | 05/15/2025 | 14.67 M | $77.59 M | 0.00% | 3.64% |
KINNEVIK AB (PUBL) | 04/28/2025 | 13.43 M | $71.07 M | 12.84% | 3.34% |
STATE STREET CORP | 05/15/2025 | 13.09 M | $69.22 M | 4.03% | 3.25% |
MUBADALA INVESTMENT CO PJSC | 05/15/2025 | 12.99 M | $68.70 M | 0.00% | 3.22% |
NOVO HOLDINGS A/S | 05/15/2025 | 9.67 M | $51.13 M | -4.44% | 2.40% |
MIC CAPITAL MANAGEMENT UK LLP | 05/15/2025 | 9.64 M | $51.02 B | 0.00% | 2.39% |
SUMITOMO MITSUI TRUST HOLDINGS, INC. | 04/25/2025 | 8.48 M | $44.86 M | -5.58% | 2.11% |
NIKKO ASSET MANAGEMENT AMERICAS, INC. | 05/07/2025 | 8.41 M | $44.39 M | -5.63% | 2.09% |
NVIDIA CORP | 05/15/2025 | 7.71 M | $40.77 M | 0.00% | 1.91% |
FMR LLC | 05/12/2025 | 6.85 M | $36.22 M | -3.19% | 1.70% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 6.44 M | $34.10 M | 5.86% | 1.60% |
UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 6.41 M | $33.90 M | 183.67% | 1.59% |
DATA COLLECTIVE IV GP, LLC | 05/15/2025 | 5.94 M | $31.43 B | 0.00% | 1.48% |
MORGAN STANLEY | 05/15/2025 | 5.01 M | $26.51 M | 75.16% | 1.24% |
DCVC OPPORTUNITY FUND II GP, LLC | 05/15/2025 | 3.95 M | $20.90 M | 0.00% | 0.98% |
EXOR CAPITAL LLP | 05/15/2025 | 3.68 M | $19.44 M | 0.00% | 0.91% |
CITADEL ADVISORS LLC | 05/15/2025 | 2.66 M | $14.05 M | -3.05% | 0.66% |
NORTHERN TRUST CORP | 05/13/2025 | 2.40 M | $12.67 M | 0.03% | 0.59% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 2.28 M | $12.05 M | 0.19% | 0.57% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 2.05 M | $10.84 M | 22.95% | 0.51% |
05/12/2025 | 1.91 M | $10.12 M | 100.00% | 0.47% | |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 1.72 M | $9.09 M | 0.51% | 0.43% |
LAURION CAPITAL MANAGEMENT LP | 05/15/2025 | 1.55 M | $8.19 M | -37.03% | 0.38% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 1.50 M | $7.91 M | -27.57% | 0.37% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 1.42 M | $7.53 M | 43.47% | 0.35% |
CITADEL ADVISORS LLC | 05/15/2025 | 1.36 M | $7.19 M | 3.90% | 0.34% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.28 M | $6.80 M | 45.54% | 0.32% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 1.16 M | $6.16 M | 1.66% | 0.29% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 1.15 M | $6.10 M | -30.59% | 0.29% |
FIRST TRUST ADVISORS LP | 05/14/2025 | 1.03 M | $5.46 M | 100.00% | 0.26% |
COMPREHENSIVE FINANCIAL MANAGEMENT LLC | 05/15/2025 | 941.90 K | $4.98 M | 0.00% | 0.23% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 863.22 K | $4.57 M | 1.48% | 0.21% |
JPMORGAN CHASE & CO | 05/12/2025 | 818.32 K | $4.33 M | -22.59% | 0.20% |
VESTMARK ADVISORY SOLUTIONS, INC. | 05/13/2025 | 706.24 K | $3.74 M | -16.44% | 0.18% |
05/15/2025 | 698.40 K | $3.69 M | 132.80% | 0.17% | |
NAN FUNG GROUP HOLDINGS LTD | 05/14/2025 | 664.61 K | $3.52 M | 0.00% | 0.17% |
CITIGROUP INC | 05/12/2025 | 659.45 K | $3.49 M | 31.63% | 0.16% |
BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 652.64 K | $3.45 M | 100.00% | 0.16% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 603.73 K | $3.19 M | 31.73% | 0.15% |
RAFFERTY ASSET MANAGEMENT, LLC | 05/14/2025 | 598.42 K | $3.17 M | 0.50% | 0.15% |
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 05/14/2025 | 595.52 K | $3.15 M | 0.00% | 0.15% |
LIONTRUST INVESTMENT PARTNERS LLP | 05/13/2025 | 595.06 K | $3.15 M | -36.13% | 0.15% |
JUMP FINANCIAL, LLC | 05/14/2025 | 592.35 K | $3.13 M | 4,289.75% | 0.15% |
BARCLAYS PLC | 05/15/2025 | 591.01 K | $3.13 M | -6.65% | 0.15% |
LAZARD ASSET MANAGEMENT LLC | 05/15/2025 | 506.14 K | $2.68 M | -8.94% | 0.13% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 502.11 K | $2.66 M | 1,673.61% | 0.12% |
Recursion Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 372 institutional investors and hedge funds held shares of Recursion Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ARK Investment Management LLC: 34.82 M
VANGUARD GROUP INC: 32.29 M
BAILLIE GIFFORD & CO: 24.39 M
BlackRock, Inc.: 23.51 M
SOFTBANK GROUP CORP.: 14.67 M
Kinnevik AB (publ): 13.43 M
75.54% of Recursion Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 327.57 M shares in the last 24 months. This purchase volume represents approximately $1.37 B in transactions.